A comparison of the biological activities of wild-type and mutant p53
- PMID: 8344485
- DOI: 10.1096/fasebj.7.10.8344485
A comparison of the biological activities of wild-type and mutant p53
Abstract
Tumorigenesis is characterized by a series of genetic alterations in both dominant oncogenes and tumor suppressor genes. A hallmark of tumor suppressor genes is that both alleles are generally altered during transformation, which usually represents a loss of function phenotype. The p53 tumor suppressor gene is the most frequently affected gene detected in human cancer. There is now growing evidence suggesting that mutation of p53 may involve not only a loss of function of wild-type p53 activity but also a gain of function phenotype contributed by the mutant p53 protein. The study of the biological properties and functions of both wild-type and mutant p53 is central to our understanding of human cancer. These properties and functions of wild-type and mutant p53 will be compared and contrasted here and elsewhere within this thematic issue. In addition, the mechanisms of inactivation of p53 function, which include: 1) mutation, 2) inhibition by viral oncogene products, 3) inhibition by cellular regulators, and 4) alteration in subcellular localization, will be discussed.
Similar articles
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
-
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.EMBO J. 1993 Mar;12(3):1029-37. doi: 10.1002/j.1460-2075.1993.tb05744.x. EMBO J. 1993. PMID: 8458321 Free PMC article.
-
Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.Int J Cancer. 2008 Apr 15;122(8):1701-9. doi: 10.1002/ijc.23317. Int J Cancer. 2008. PMID: 18092324
-
Mutant p53: gain-of-function oncoproteins and wild-type p53 inactivators.Biol Chem. 1999 Jul-Aug;380(7-8):879-87. doi: 10.1515/BC.1999.108. Biol Chem. 1999. PMID: 10494837 Review.
-
The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.Am J Gastroenterol. 1993 Feb;88(2):174-86. Am J Gastroenterol. 1993. PMID: 8424417 Review.
Cited by
-
Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human colon carcinoma LoVo/5-FU cells.World J Gastroenterol. 2004 Jul 1;10(13):1979-83. doi: 10.3748/wjg.v10.i13.1979. World J Gastroenterol. 2004. PMID: 15222051 Free PMC article.
-
Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells.J Gastroenterol. 1997 Jun;32(3):330-7. doi: 10.1007/BF02934489. J Gastroenterol. 1997. PMID: 9213246
-
Expression of mdm-2 and p53 protein in transitional cell carcinoma.Urol Res. 1995;22(6):349-52. doi: 10.1007/BF00296873. Urol Res. 1995. PMID: 7537927
-
Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions.Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10315-20. doi: 10.1073/pnas.93.19.10315. Proc Natl Acad Sci U S A. 1996. PMID: 8816797 Free PMC article.
-
MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection.J Virol. 1997 Oct;71(10):7609-18. doi: 10.1128/JVI.71.10.7609-7618.1997. J Virol. 1997. PMID: 9311842 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
